Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)James R. Berenson, Robert Vescio, Noemi Silagan et al.|Blood|2020Cited by 2
Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Shahrooz Eshaghian et al.|Blood|2022Cited by 2
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and MethylprednisoloneJames R. Berenson, Robert Vescio, Andrea Limon et al.|Targeted Oncology|2024Cited by 2
Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Mehdi M. Moezi et al.|Blood|2021Cited by 1